Burton DR - Search Results

1

Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.

Walker LM, Burton DR. Walker LM, et al. Among authors: burton dr. Nat Rev Immunol. 2018 May;18(5):297-308. doi: 10.1038/nri.2017.148. Epub 2018 Jan 30. Nat Rev Immunol. 2018. PMID: 29379211 Free PMC article. Review.

2

Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries.

Duchosal MA, Eming SA, Fischer P, Leturcq D, Barbas CF 3rd, McConahey PJ, Caothien RH, Thornton GB, Dixon FJ, Burton DR. Duchosal MA, et al. Among authors: burton dr. Nature. 1992 Jan 16;355(6357):258-62. doi: 10.1038/355258a0. Nature. 1992. PMID: 1731222

3

Antibodies in human infectious disease.

Parren PW, Poignard P, Ditzel HJ, Williamson RA, Burton DR. Parren PW, et al. Among authors: burton dr. Immunol Res. 2000;21(2-3):265-78. doi: 10.1385/IR:21:2-3:265. Immunol Res. 2000. PMID: 10852127 Review.

4

The antiviral activity of antibodies in vitro and in vivo.

Parren PW, Burton DR. Parren PW, et al. Among authors: burton dr. Adv Immunol. 2001;77:195-262. doi: 10.1016/s0065-2776(01)77018-6. Adv Immunol. 2001. PMID: 11293117 Free PMC article. Review.

5

Antibodies, viruses and vaccines.

Burton DR. Burton DR. Nat Rev Immunol. 2002 Sep;2(9):706-13. doi: 10.1038/nri891. Nat Rev Immunol. 2002. PMID: 12209139 Review.

6

HIV vaccine design and the neutralizing antibody problem.

Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT. Burton DR, et al. Nat Immunol. 2004 Mar;5(3):233-6. doi: 10.1038/ni0304-233. Nat Immunol. 2004. PMID: 14985706 No abstract available.

7

Fc receptor but not complement binding is important in antibody protection against HIV.

Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR. Hessell AJ, et al. Among authors: burton dr. Nature. 2007 Sep 6;449(7158):101-4. doi: 10.1038/nature06106. Nature. 2007. PMID: 17805298

8

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.

Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI, Ball JK, McKeating JA, Kneteman NM, Burton DR. Law M, et al. Among authors: burton dr. Nat Med. 2008 Jan;14(1):25-7. doi: 10.1038/nm1698. Epub 2007 Dec 6. Nat Med. 2008. PMID: 18064037

9

Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library.

Walker LM, Bowley DR, Burton DR. Walker LM, et al. Among authors: burton dr. J Mol Biol. 2009 Jun 5;389(2):365-75. doi: 10.1016/j.jmb.2009.04.019. Epub 2009 Apr 16. J Mol Biol. 2009. PMID: 19376130 Free PMC article.

10

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC. Simek MD, et al. Among authors: burton dr. J Virol. 2009 Jul;83(14):7337-48. doi: 10.1128/JVI.00110-09. Epub 2009 May 13. J Virol. 2009. PMID: 19439467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

659 results

Search Page